Works matching AU Hutchings, Martin

Results: 70
    1
    2
    3
    4
    5
    6
    7
    8

    NOTCH1 Mutations Are Associated With Therapy‐Resistance in Patients With B‐Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 712, doi. 10.1002/ajh.27601
    By:
    • Kyvsgaard, Emil R.;
    • Grauslund, Morten;
    • Sjø, Lene;
    • Melchior, Linea Cecilie;
    • Grantzau, Trine Lønbo;
    • Gjerdrum, Lise Mette Rahbek;
    • Trab, Trine;
    • Andersen, Lærke Sloth;
    • Gang, Anne Ortved;
    • Breinholt, Marie;
    • Møller, Michael Boe;
    • Haaber Christensen, Jacob;
    • Larsen, Thomas Stauffer;
    • Clausen, Michael Roost;
    • Riley, Caroline H.;
    • Niemann, Carsten U.;
    • Grønbæk, Kirsten;
    • Hutchings, Martin;
    • Husby, Simon
    Publication type:
    Article
    9
    10

    Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish- Canadian study of 443 patients with diffuse-large B-cell lymphoma.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 11, p. 1041, doi. 10.1002/ajh.24169
    By:
    • El-Galaly, Tarec Christoffer;
    • Villa, Diego;
    • Alzahrani, Musa;
    • Hansen, Jakob Werner;
    • Sehn, Laurie H.;
    • Wilson, Don;
    • de Nully Brown, Peter;
    • Loft, Annika;
    • Iyer, Victor;
    • Johnsen, Hans Erik;
    • Savage, Kerry J.;
    • Connors, Joseph M.;
    • Hutchings, Martin
    Publication type:
    Article
    11
    12

    Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 6, p. 575, doi. 10.1002/ajh.23688
    By:
    • El-Galaly, TC;
    • Mylam, Karen Juul;
    • Bøgsted, Martin;
    • Brown, Peter;
    • Rossing, Maria;
    • Gang, Anne Ortved;
    • Haglund, Anne;
    • Arboe, Bente;
    • Clausen, Michael Roost;
    • Jensen, Paw;
    • Pedersen, Michael;
    • Bukh, Anne;
    • Jensen, Bo Amdi;
    • Poulsen, Christian Bjørn;
    • d'Amore, Francesco;
    • Hutchings, Martin
    Publication type:
    Article
    13
    14

    Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 18, p. 6565, doi. 10.1002/cam4.3298
    By:
    • André, Marc P. E.;
    • Carde, Patrice;
    • Viviani, Simonetta;
    • Bellei, Monica;
    • Fortpied, Catherine;
    • Hutchings, Martin;
    • Gianni, Alessandro M.;
    • Brice, Pauline;
    • Casasnovas, Olivier;
    • Gobbi, Paolo G.;
    • Zinzani, Pier Luigi;
    • Dupuis, Jehan;
    • Iannitto, Emilio;
    • Rambaldi, Alessandro;
    • Brière, Josette;
    • Clément‐Filliatre, Laurianne;
    • Heczko, Marian;
    • Valagussa, Pinuccia;
    • Douxfils, Jonathan;
    • Depaus, Julien
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    High‐dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited‐stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial

    Published in:
    HemaSphere, 2025, v. 9, n. 4, p. 1, doi. 10.1002/hem3.70105
    By:
    • Manuel, Gotti;
    • Stepanishyna, Yana;
    • Skrypets, Tetiana;
    • Marcheselli, Luigi;
    • Cristinelli, Caterina;
    • Botto, Barbara;
    • Tonino, Sanne;
    • Cavalieri, Doriane;
    • Pulsoni, Alessandro;
    • Hutchings, Martin;
    • Hammoud, Mohammad;
    • Fortpied, Catherine;
    • Rigacci, Luigi;
    • Plattel, Wouter;
    • André, Marc;
    • Federico, Massimo
    Publication type:
    Article
    22
    23

    P1118: LONGER FOLLOW‐UP FROM THE PIVOTAL EPCORE NHL‐1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971368.08106.5c
    By:
    • Jurczak, Wojciech;
    • Ghesquieres, Herve;
    • Karimi, Yasmin;
    • Cheah, Chan;
    • Roost Clausen, Michael;
    • Cunningham, David;
    • Rok Do, Young;
    • Lewis, David;
    • Gasiorowski, Robin;
    • Min Kim, Tae;
    • Poel, Marjolein Van Der;
    • Limei Poon, Michelle;
    • Feldman, Tatyana;
    • Linton, Kim;
    • Sureda, Anna;
    • Hutchings, Martin;
    • Kanoun, Salim;
    • Vercellino, Laetitia;
    • Cota Stirner, Mariana;
    • Mcgoldrick, Stephanie
    Publication type:
    Article
    24

    P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971412.45898.1a
    By:
    • Hutchings, Martin;
    • Carlo‐Stella, Carmelo;
    • Morschhauser, Franck;
    • Dickinson, Michael;
    • Bachy, Emmanuel;
    • Cartron, Guillaume;
    • Khan, Cyrus;
    • Tani, Monica;
    • Martinez‐Lopez, Joaquín;
    • Bartlett, Nancy L.;
    • Salar, Antonio;
    • Brody, Joshua;
    • Leppa, Sirpa;
    • Baumlin, Pauline;
    • Lundberg, Linda;
    • Relf, James;
    • Xie, Yuying;
    • Bottos, Alessia;
    • Humphrey, Kathryn;
    • Falchi, Lorenzo
    Publication type:
    Article
    25

    S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN PATIENTS WITH HIGH‐RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967800.55471.36
    By:
    • Sureda, Anna;
    • Falchi, Lorenzo;
    • Leppa, Sirpa;
    • Vermaat, Joost;
    • Holte, Harald;
    • Hutchings, Martin;
    • Lugtenburg, Pieternella;
    • de Vos, Sven;
    • Abrisqueta, Pau;
    • Nijland, Marcel;
    • Merryman, Reid W.;
    • Christensen, Jacob Haaber;
    • Wahlin, Bjorn;
    • Linton, Kim;
    • Wang, Liwei;
    • Abbas, Aqeel;
    • Rana, Ali;
    • Quadri, Syed;
    • Belada, David
    Publication type:
    Article
    26
    27

    P025: RADAR: An international phase III, PET response‐adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited‐stage classical Hodgkin lymphoma.

    Published in:
    HemaSphere, 2022, v. 6, p. 12, doi. 10.1097/01.HS9.0000890668.27643.97
    By:
    • Radford, John;
    • Adedayo, Toyin;
    • Ardavan, Arzhang;
    • Barrington, Sally F.;
    • Berkahn, Leanne;
    • Chauvie, Stephane;
    • Clifton‐Hadley, Laura;
    • Collins, Graham P.;
    • Crump, Michael;
    • Cutter, David;
    • Edwards, Darren;
    • Hutchings, Martin;
    • Illidge, Tim;
    • Kirkwood, Amy A.;
    • Linton, Kim;
    • Moskowitz, Craig H.;
    • Patrick, Pip;
    • Phillips, Beth;
    • Shepherd, Lois;
    • Tonino, Sanne
    Publication type:
    Article
    28

    P009: Improved Overall Survival with First‐Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON‐1.

    Published in:
    HemaSphere, 2022, v. 6, p. 4, doi. 10.1097/01.HS9.0000890604.66330.a0
    By:
    • Hutchings, Martin;
    • Ansell, Stephen M.;
    • Connors, Joseph M.;
    • Kim, Won Seog;
    • Gallamini, Andrea;
    • Ramchandren, Radhakrishnan;
    • Friedberg, Jonathan W.;
    • Advani, Ranjana;
    • Evens, Andrew M.;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Eom, Hyeon‐Seok;
    • Abramson, Jeremy S.;
    • Dong, Cassie;
    • Campana, Frank;
    • Fenton, Keenan;
    • Puhlmann, Markus;
    • Straus, David J.;
    • Radford, John
    Publication type:
    Article
    29

    T001: FDG‐PET and serum TARC levels after one cycle of BV‐AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET‐response adapted EORTC‐COBRA trial.

    Published in:
    HemaSphere, 2022, v. 6, p. 1, doi. 10.1097/01.HS9.0000890572.92604.2c
    By:
    • Diepstra, Arjan;
    • Visser, Lydia;
    • Fortpied, Catherine;
    • Noordzij, Walter;
    • Loft, Annika;
    • Arens, Anne;
    • Sureda‐Balari, Anna;
    • Carvalho, Susana;
    • Vranovský, Andrej;
    • Sents, Ward;
    • Buhrer, Emanuel;
    • Plattel, Wouter J.;
    • Hutchings, Martin
    Publication type:
    Article
    30
    31

    Relationships, marriage, and partner abandonment among Hodgkin lymphoma survivors treated in nine EORTC-GELA Lymphoma Group trials.

    Published in:
    2024
    By:
    • Rossetti, Sára;
    • Juul, Sidsel J.;
    • van der Kaaij, Marleen A. E.;
    • Fortpied, Catherine;
    • Meijnders, Paul;
    • Aleman, Berthe M. P.;
    • Raemaekers, John M. M.;
    • Kluin‑Nelemans, Hanneke C.;
    • Spina, Michele;
    • Fermé, Christophe;
    • Renaud, Loïc;
    • Casasnovas, Olivier;
    • Stamatoullas, Aspasia;
    • Plattel, Wouter J.;
    • Hutchings, Martin;
    • Maraldo, Maja V.
    Publication type:
    Letter to the Editor
    32

    <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 7, p. 2005, doi. 10.3109/10428194.2014.975800
    By:
    • Mylam, Karen Juul;
    • Kostakoglu, Lale;
    • Hutchings, Martin;
    • Coleman, Morton;
    • Lamonica, Dominick;
    • Czuczman, Myron S.;
    • Diehl, Louis F.;
    • Nielsen, Anne L.;
    • Jensen, Paw;
    • Loft, Annika;
    • Hendel, Helle W.;
    • Iyer, Victor;
    • Leppä, Sirpa;
    • Jyrkkiö, Sirkku;
    • Holte, Harald;
    • Eriksson, Mikael;
    • Gillstrøm, Dorte;
    • Hansen, Per B.;
    • Seppänen, Marko;
    • Hjorthaug, Karin
    Publication type:
    Article
    33

    Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 5, p. 1233, doi. 10.3109/10428194.2015.1034707
    By:
    • Zwarthoed, Cholette;
    • Ouvier, Matthieu John;
    • Borra, Anna;
    • Bergesio, Fabrizio;
    • Chauvie, Stephane;
    • Biggi, Alberto;
    • Hutchings, Martin;
    • El-Galaly, Tarek;
    • Gallamini, Andrea;
    • Simon, Zsófia;
    • Miltényi, Zsófia;
    • Magyari, Ferenc;
    • Barna, Sándor;
    • Kenyeres, Anna;
    • Jóna, Ádám;
    • Illés, Árpád;
    • Dann, Eldad J.;
    • Bar-Shalom, Rachel;
    • Kagana, Olga;
    • Bairey, Osnat
    Publication type:
    Article
    34
    35

    Impact of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 10, p. 2349, doi. 10.3109/10428194.2013.875169
    By:
    • El-Galaly, Tarec Christoffer;
    • Hutchings, Martin;
    • Mylam, Karen Juul;
    • Brown, Peter de Nully;
    • Bukh, Anne;
    • Johnsen, Hans Erik;
    • Kamper, Peter;
    • Loft, Annika;
    • Iyer, Victor;
    • Gormsen, Lars Christian;
    • Nielsen, Anne Lerberg;
    • Bøgsted, Martin;
    • d'Amore, Francesco
    Publication type:
    Article
    36

    Prognostic impact of clinician-based interpretation of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 7, p. 1563, doi. 10.3109/10428194.2013.850165
    By:
    • Mylam, Karen J.;
    • El-Galaly, Tarec C.;
    • Hutchings, Martin;
    • Brown, Peter;
    • Himmelstrup, Bodil;
    • Gerke, Oke;
    • Gillstrøm, Dorte;
    • Sillesen, Ida B.;
    • Munksgaard, Lars;
    • Pedersen, Bjarne B.;
    • Christiansen, Ilse;
    • Jensen, Paw;
    • Nielsen, Anne L.;
    • Pedersen, Lars M.
    Publication type:
    Article
    37
    38

    Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim <sup>18</sup>F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.

    Published in:
    Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 410, doi. 10.23736/S1824-4785.17.02993-4
    By:
    • BIGGI, Alberto;
    • BERGESIO, Fabrizio;
    • CHAUVIE, Stephane;
    • BIANCHI, Andrea;
    • MENGA, Massimo;
    • FALLANCA, Federico;
    • HUTCHINGS, Martin;
    • GREGIANIN, Michele;
    • MEIGNAN, Michel;
    • GALLAMINI, Andrea
    Publication type:
    Article
    39

    Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 5, p. 848, doi. 10.1002/hon.3209
    By:
    • Hamadani, Mehdi;
    • Coleman, Morton;
    • Boccia, Ralph;
    • Duras, Juraj;
    • Hutchings, Martin;
    • Zinzani, Pier Luigi;
    • Cordoba, Raul;
    • Oreiro, Mariana Bastos;
    • Williams, Vanessa;
    • Liu, Huiqing;
    • Stouffs, Michael;
    • Langmuir, Peter;
    • Sancho, Juan‐Manuel
    Publication type:
    Article
    40

    Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
    By:
    • Hutchings, Martin;
    • Radford, John;
    • Ansell, Stephen M.;
    • Illés, Árpád;
    • Sureda, Anna;
    • Connors, Joseph M.;
    • Sýkorová, Alice;
    • Shibayama, Hirohiko;
    • Abramson, Jeremy S.;
    • Chua, Neil S.;
    • Friedberg, Jonathan W.;
    • Kořen, Jan;
    • LaCasce, Ann Steward;
    • Molina, Lysiane;
    • Engley, Gerald;
    • Fenton, Keenan;
    • Jolin, Hina;
    • Liu, Rachael;
    • Gautam, Ashish;
    • Gallamini, Andrea
    Publication type:
    Article
    41
    42
    43
    44

    FDG-PET/CT based response-adapted treatment.

    Published in:
    Cancer Imaging, 2012, v. 12, n. 2, p. 324, doi. 10.1102/1470-7330.2012.9006
    By:
    • de Geus-Oei, Lioe-Fee;
    • Vriens, Dennis;
    • Arens, Anne I. J.;
    • Hutchings, Martin;
    • Oyen, Wim J. G.
    Publication type:
    Article
    45
    46
    47
    48

    Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 4, p. 1374, doi. 10.1111/bjh.19586
    By:
    • Rossetti, Sára;
    • Juul, Sidsel Jacobsen;
    • Eriksson, Frank;
    • Warming, Peder Emil;
    • Glinge, Charlotte;
    • El‐Galaly, Tarec Christoffer;
    • Haaber Christensen, Jacob;
    • Kamper, Peter;
    • de Nully Brown, Peter;
    • Gislason, Gunnar Hilmar;
    • Vestmø Maraldo, Maja;
    • Tfelt‐Hansen, Jacob;
    • Hutchings, Martin
    Publication type:
    Article
    49

    Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 2, p. 542, doi. 10.1111/bjh.19475
    By:
    • Vandtved, Julie Haugaard;
    • Øvlisen, Andreas Kiesbye;
    • Baech, Joachim;
    • Weinrich, Ulla Møller;
    • Severinsen, Marianne Tang;
    • Maksten, Eva Futtrup;
    • Jakobsen, Lasse Hjort;
    • Glimelius, Ingrid;
    • Kamper, Peter;
    • Hutchings, Martin;
    • Specht, Lena;
    • Dahl‐Sørensen, Rasmus;
    • Christensen, Jacob Haaber;
    • El‐Galaly, Tarec C.
    Publication type:
    Article
    50